Harrow Health Stock Filter Stocks by Fundamentals
| HROW Stock | USD 42.47 0.23 0.54% |
Harrow Health fundamentals help investors to digest information that contributes to Harrow Health's financial success or failures. It also enables traders to predict the movement of Harrow Stock. The fundamental analysis module provides a way to measure Harrow Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harrow Health stock.
Harrow | Shares Owned by Institutions |
Harrow Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Harrow Health from analyzing Harrow Health's financial statements. These drivers represent accounts that assess Harrow Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harrow Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 197.0M | 177.6M | 231.2M | 405.3M | 365.3M | 383.6M | |
| Enterprise Value | 213.3M | 197.1M | 267.0M | 413.2M | 481.7M | 505.8M |
Harrow Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Harrow Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Harrow Health's managers, analysts, and investors.Environmental | Governance | Social |
Harrow Health Institutional Holders
Institutional Holdings refers to the ownership stake in Harrow Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Harrow Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Harrow Health's value.| Shares | First Turn Management Llc | 2024-09-30 | 326.6 K | Rice Hall James & Associates, Llc | 2024-09-30 | 314.9 K | Northern Trust Corp | 2024-09-30 | 296.8 K | Renaissance Technologies Corp | 2024-09-30 | 293.8 K | Deutsche Bank Ag | 2024-06-30 | 284 K | Charles Schwab Investment Management Inc | 2024-09-30 | 251.6 K | Voloridge Investment Management, Llc | 2024-09-30 | 215.7 K | Westside Investment Management, Inc. | 2024-06-30 | 209.9 K | Gilder Gagnon Howe & Co Llc | 2024-09-30 | 209.5 K | Opaleye Management Inc | 2024-09-30 | 4 M | Private Capital Management, Llc | 2024-09-30 | 2.2 M |
Harrow Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.0168 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.63 B | ||||
| Shares Outstanding | 35.61 M | ||||
| Shares Owned By Insiders | 14.11 % | ||||
| Shares Owned By Institutions | 59.16 % | ||||
| Number Of Shares Shorted | 2.51 M | ||||
| Price To Earning | 24.45 X | ||||
| Price To Book | 25.95 X | ||||
| Price To Sales | 8.94 X | ||||
| Revenue | 130.19 M | ||||
| Gross Profit | 63.21 M | ||||
| EBITDA | 9.72 M | ||||
| Net Income | (24.41 M) | ||||
| Cash And Equivalents | 51.7 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 190.5 M | ||||
| Current Ratio | 5.01 X | ||||
| Book Value Per Share | 1.64 X | ||||
| Cash Flow From Operations | 3.84 M | ||||
| Short Ratio | 3.76 X | ||||
| Earnings Per Share | (0.96) X | ||||
| Price To Earnings To Growth | (2.50) X | ||||
| Target Price | 60.85 | ||||
| Number Of Employees | 315 | ||||
| Beta | 0.76 | ||||
| Market Capitalization | 1.51 B | ||||
| Total Asset | 311.75 M | ||||
| Retained Earnings | (133.9 M) | ||||
| Working Capital | 90.14 M | ||||
| Current Asset | 8.77 M | ||||
| Current Liabilities | 2.56 M | ||||
| Net Asset | 311.75 M |
About Harrow Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harrow Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harrow Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harrow Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Harrow Stock Analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.